POTENT INHIBITION OF RECOMBINANT HUMAN CYTOCHROME P-450 1A1 BY PENTAMETHOXYSTILBENE

REFERENCES

• Burke , M. D. , Thompson , S. , Elcombe , C. R. , Halpert , J. , Haaparanta , T. and Mayer , R. T. 1985 . Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450 . Biochem. Phamacol. , 34 : 3337 – 3345 .
   PubMed Web of Science ®Google Scholar
• Cai , Y. , Baer-Dubowska , W. , Ashwood-Smith , M. J. , Ceska , O. , Tachibana , S. and DiGiovanni , J. 1996 . Mechanism-based inactivation of hepatic ethoxyresorufin O-dealkylation activity by naturally occurring coumarins . Chem. Res. Toxicol. , 9 : 729 – 736 .
   PubMed Web of Science ®Google Scholar
• Chan , W. K. and Delucchi , A. B. 2000 . Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4 . Life Sci. , 67 : 3103 – 3112 .
   PubMed Web of Science ®Google Scholar
• Chun , Y. J. and Kim , S. 2003 . Discovery of cytochrome P450 1B1 inhibitors as new promising anti-cancer agents . Med. Res. Rev. , 23 : 657 – 668 .
   PubMed Web of Science ®Google Scholar
• Chun , Y. J. , Kim , M. Y. and Guengerich , F. P. 1999 . Resveratrol is a selective human cytochrome P450 1A1 inhibitor . Biochem. Biophys. Res. Commun. , 262 : 20 – 24 .
   PubMed Web of Science ®Google Scholar
• Chun , Y. J. , Kim , S. , Kim , D. , Lee , S. K. and Guengerich , F. P. 2001a . A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis . Cancer Res. , 61 : 8164 – 8170 .
   PubMed Web of Science ®Google Scholar
• Chun , Y. J. , Ryu , S. Y. , Jeong , T. C. and Kim , M. Y. 2001b . Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin . Drug Metab. Dispos. , 29 : 389 – 393 .
   PubMed Web of Science ®Google Scholar
• Ciolino , H. P. and Yeh , G. C. 1999 . Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol . Mol. Pharmacol. , 56 : 760 – 767 .
   PubMed Web of Science ®Google Scholar
• Ciolino , H. P. , Daschner , P. J. and Yeh , G. C. 1998 . Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor . Cancer Res. , 58 : 5707 – 5712 .
   PubMed Web of Science ®Google Scholar
• Denison , M. S. , Fisher , J. H. and Whitlock , J. P. 1989 . Protein–DNA interactions at recognition sites for the dioxin–Ah receptor complex . J. Biol. Chem. , 264 : 16478 – 16482 .
   PubMed Web of Science ®Google Scholar
• Dolwick , K. M. , Swanson , H. I. and Bradfield , C. A. 1993 . In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition . Proc. Natl. Acad. Sci. USA , 90 : 8566 – 8570 .
   PubMed Web of Science ®Google Scholar
• Fujino , T. , Park , S. S. , West , D. and Gelboin , H. V. 1982 . Phenotyping of cytochromes P-450 in human tissues with monoclonal antibodies . Proc. Natl. Acad. Sci. USA , 79 : 3682 – 3686 .
   PubMed Web of Science ®Google Scholar
• Guengerich , F. P. 1994 . “ Analysis and characterization of enzymes ” . In Principles and methods of toxicology, , Edited by: Hayes , A. W. 1259 – 1313 . New York : Raven Press .
   Google Scholar
• Guengerich , F. P. , Shimada , T. , Bondon , A. and Macdonald , T. L. 1991 . Cytochrome P-450 oxidations and the generation of biologically reactive intermediates . Adv. Exp. Med. Biol. , 283 : 1 – 11 .
   PubMedGoogle Scholar
• Guengerich , F. P. , Martin , M. V. , Guo , Z. and Chun , Y. J. 1996 . Purification of functional recombinant P450s from bacteria . Methods Enzymol. , 272 : 35 – 44 .
   PubMed Web of Science ®Google Scholar
• Henderson , M. C. , Miranda , C. L. , Stevens , J. F. , Deinzer , M. L. and Buhler , D. R. 2000 . In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus . Xenobiotica , 30 : 235 – 251 .
   PubMed Web of Science ®Google Scholar
• Kim , S. , Ko , H. , Park , J. E. , Jung , S. , Lee , S. K. and Chun , Y. J. 2002 . Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors . J. Med. Chem. , 45 : 160 – 164 .
   PubMed Web of Science ®Google Scholar
• Laemmli , U. K. 1970 . Cleavage of structural proteins during the assembly of the head of bacteriophage T4 . Nature , 227 : 680 – 685 .
   PubMed Web of Science ®Google Scholar
• Lee , J. E. and Safe , S. 2001 . Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by resveratrol in breast cancer cells . Biochem. Pharmacol. , 62 : 1113 – 1124 .
   PubMed Web of Science ®Google Scholar
• Li , W. , Harper , P. A. , Tang , B. K. and Okey , A. B. 1998 . Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cells: CYP1A2 expression in the LS180 colon carcinoma cell line after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 3-methylcholanthrene . Biochem. Pharmacol. , 56 : 599 – 612 .
   PubMed Web of Science ®Google Scholar
• Matsuda , H. , Tomohiro , N. , Hiraba , K. , Harimu , S. , Ko , S. , Matsuo , K. , Yoshikawa , M. and Kubo , M. 2001 . Study on anti-Oketsu activity of rhubarb II. Anti-allergic effects of stilbene components from Rhei undulati rhizoma (dried rhizome of Rheum undulatum cultivated in Korea) . Biol. Pharm. Bull. , 24 : 264 – 267 .
   PubMed Web of Science ®Google Scholar
• Nebert , D. W. 1989 . The Ah locus: Genetic differences in toxicity, cancer, mutation, and birth defects . Crit. Rev. Toxicol. , 20 : 153 – 174 .
   PubMed Web of Science ®Google Scholar
• Omura , T. and Sato , R. 1964 . The carbon-monoxide binding pigment of liver microsomes . J. Biol. Chem. , 239 : 2370 – 2378 .
   PubMed Web of Science ®Google Scholar
• Parikh , A. , Gillam , E. M. J. and Guengerich , F. P. 1997 . Drug metabolism by Escherichia coli expressing human cytochromes P450 . Nat. Biotechnol. , 15 : 784 – 788 .
   PubMed Web of Science ®Google Scholar
• Reyes , H. , Reisz-Porezasz , S. and Hankinson , O. 1992 . Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor . Science , 256 : 1193 – 1195 .
   PubMed Web of Science ®Google Scholar
• Rowlands , J. C. and Gustafsson , J. A. 1997 . Aryl hydrocarbon receptor-mediated signal transduction . Crit. Rev. Toxicol. , 27 : 109 – 134 .
   PubMed Web of Science ®Google Scholar
• Shimada , T. , Yamazaki , H. , Foroozesh , M. , Hopkins , N. E. , Alworth , W. L. and Guengerich , F. P. 1998 . Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1 . Chem. Res. Toxicol. , 11 : 1048 – 1056 .
   PubMed Web of Science ®Google Scholar
• Swanson , H. I. and Bradfield , C. A. 1993 . The AH-receptor: genetics, structure and function . Pharmacogenetics , 3 : 213 – 230 .
   PubMedGoogle Scholar
• Wedlund , P. J. , Kimura , S. , Gonzalez , F. J. and Nebert , D. W. 1994 . 1462V mutation in the human CYP1A1 gene: Lack of correlation with either the Msp I 1.9 kb (M2) allele or CYP1A1 inducibility in a three-generation family of east Mediterranean descent . Phamacogenetics , 4 : 21 – 26 .
   PubMedGoogle Scholar
• Whitlock , J. P. 1999. . Induction of cytochrome P450 1A1 . Annu. Rev. Phamacol. Toxicol. , 39 : 103 – 125 .
   PubMed Web of Science ®Google Scholar
• Yang , C. S. , Smith , T. J. and Hong , J. Y. 1994 . Cytochrome P450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity opportunities and limitations . Cancer Res. , 54 : 1982s – 1986s .
   PubMed Web of Science ®Google Scholar
• Zhai , S. , Dai , R. , Friedman , F. K. and Vestal , R. E. 1998 . Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids . Drug Metab. Dispos. , 26 : 989 – 992 .
   PubMed Web of Science ®Google Scholar